Tricyclic compounds as inhibitors of KRAS
US-12441727-B2 · Oct 14, 2025 · US
This page is not indexed by search engines while we improve data quality.
Gan Pei patents
Gan Pei is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Gan Pei |
| Total patents | 18 |
| First publication | Sep 26, 2019 |
| Latest publication | Oct 14, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
US-2025313567-A1 · Oct 9, 2025 · US
Tricyclic compounds as inhibitors of kras
US-2025188073-A1 · Jun 12, 2025 · US
Fused pyrazine derivatives as a2a / a2b inhibitors
US-2024360140-A1 · Oct 31, 2024 · US
Vinyl imidazole compounds as inhibitors of kras
US-2024343742-A1 · Oct 17, 2024 · US
Fused pyrazine derivatives as A2A / A2B inhibitors
US-11999740-B2 · Jun 4, 2024 · US
Vinyl imidazole compounds as inhibitors of KRAS
US-11999752-B2 · Jun 4, 2024 · US
Fused tricyclic compounds as inhibitors of kras g12v mutants
US-2024101557-A1 · Mar 28, 2024 · US
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
US-2023357255-A1 · Nov 9, 2023 · US
Combination therapy comprising an fgfr inhibitor and a kras inhibitor
US-2023226040-A1 · Jul 20, 2023 · US
Recent patents
Latest publications not already listed above.
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
US-11673894-B2 · Jun 13, 2023 · US
Tricyclic compounds as inhibitors of kras
US-2023056631-A1 · Feb 23, 2023 · US
Fused pyrazine derivatives as a2a / a2b inhibitors
US-2022135570-A1 · May 5, 2022 · US
Vinyl imidazole compounds as inhibitors of kras
US-2022064188-A1 · Mar 3, 2022 · US
Tricyclic compounds as inhibitors of kras
US-2021269434-A1 · Sep 2, 2021 · US
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
US-2021139485-A1 · May 13, 2021 · US
Fused pyrazine derivatives as a2a / a2b inhibitors
US-2020031835-A1 · Jan 30, 2020 · US
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
US-2019292188-A1 · Sep 26, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Incyte Corp | 18 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 18 |
| C07D519/00 | 14 |
| C07D487/04 | 14 |
| A61P29/00 | 11 |
| A61P9/00 | 9 |